The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase 2 trial of veliparib (V), radiotherapy (RT) and temozolomide (TMZ) in patients (pts) with unmethylated MGMT (uMGMT) glioblastoma (GBM): Feasibility and safety outcomes (the VERTU study).
 
Mustafa Khasraw
Honoraria - Pfizer
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Lilly
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Specialised Therapeutics (Inst)
 
Kerrie Leanne McDonald
Consulting or Advisory Role - Abbvie
 
Mark Rosenthal
No Relationships to Disclose
 
Zarnie Lwin
Consulting or Advisory Role - Abbvie
 
David M. Ashley
No Relationships to Disclose
 
Helen Wheeler
No Relationships to Disclose
 
Elizabeth Barnes
No Relationships to Disclose
 
Eng-Siew Koh
No Relationships to Disclose
 
Matthew C Foote
No Relationships to Disclose
 
Michael Buckland
Honoraria - Abbvie
 
Lauren Fisher
Research Funding - Abbvie (Inst)
 
Robyn Leonard
No Relationships to Disclose
 
Merryn Hall
Research Funding - Abbvie (Inst)
 
Sonia Yip
No Relationships to Disclose
 
John Simes
No Relationships to Disclose